Building a comprehensive toolbox for oligonucleotide drug discovery

11:20 AM - 11:40 AM (PDT), Tuesday, June 14, 2022

Recent years have seen tremendous progress in the application of RNA/DNA based therapeutics, with successful treatments reaching the market and the potential for widespread applications becoming a realizable objective. In parallel the diversity of application of this modality is rapidly expanding to encompass not just gene silencing but also splice modulation and gene activation, as well as demonstrating potential to target patient-specific sequences that are causative for rare diseases. We are committed to helping diverse research teams achieve the full potential of oligonucleotide therapeutics, and have been diligently building a comprehensive platform to support this.